U.S. Markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.80-3.70 (-5.32%)
At close: 4:00PM EDT
People also watch
BMRNACORSGENACADALXN
Currency in USD

Valuation Measures

Market Cap (intraday) 55.67B
Enterprise Value 3N/A
Trailing P/E -13.62
Forward P/E 1-13.19
PEG Ratio (5 yr expected) 1-0.28
Price/Sales (ttm)96.49
Price/Book (mrq)6.82
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-716.42%
Management Effectiveness
Return on Assets (ttm)-21.48%
Return on Equity (ttm)-41.03%
Income Statement
Revenue (ttm)58.77M
Revenue Per Share (ttm)0.69
Quarterly Revenue Growth (yoy)158.10%
Gross Profit (ttm)47.16M
EBITDA -407.54M
Net Income Avi to Common (ttm)-414.42M
Diluted EPS (ttm)-4.83
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)559.6M
Total Cash Per Share (mrq)6.49
Total Debt (mrq)150M
Total Debt/Equity (mrq)18.05
Current Ratio (mrq)6.24
Book Value Per Share (mrq)9.65
Cash Flow Statement
Operating Cash Flow (ttm)-324.41M
Levered Free Cash Flow (ttm)-241.77M

Trading Information

Stock Price History
Beta 3.50
52-Week Change 3-3.10%
S&P500 52-Week Change 315.17%
52 Week High 380.11
52 Week Low 331.38
50-Day Moving Average 357.45
200-Day Moving Average 348.37
Share Statistics
Avg Vol (3 month) 31.1M
Avg Vol (10 day) 31.63M
Shares Outstanding 586.19M
Float 71.25M
% Held by Insiders 112.85%
% Held by Institutions 179.00%
Shares Short 310.4M
Short Ratio 312.01
Short % of Float 325.49%
Shares Short (prior month) 310.19M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A